CompanyScope

Astera Labs, Inc. revenue by year

Ticker ALAB · SEC CIK 1736297 · Latest fiscal year ended Dec 31, 2025

Over the 4 fiscal years shown, revenue went from $79.87M (year ended Dec 31, 2022) to $852.52M (year ended Dec 31, 2025), a compound annual growth rate of 120.1%. The fastest growth was +242.2% in the year ended Dec 31, 2024; the weakest year was +45.0% (year ended Dec 31, 2023).

$0$250M$500M$750M$1BDec 2022: $79.87MDec 2023: $115.79MDec 2024: $396.29MDec 2025: $852.52MDec 2022Dec 2023Dec 2024Dec 2025
Astera Labs, Inc. revenue by fiscal year, USD. Hover a bar for the exact figure.

Annual revenue

Fiscal year endedRevenue (USD)ChangeXBRL conceptReported in
Dec 31, 2025$852.52M+115.1%RevenueFromContractWithCustomerExcludingAssessedTax10-K filed Feb 20, 2026
Dec 31, 2024$396.29M+242.2%RevenueFromContractWithCustomerExcludingAssessedTax10-K filed Feb 20, 2026
Dec 31, 2023$115.79M+45.0%RevenueFromContractWithCustomerExcludingAssessedTax10-K filed Feb 20, 2026
Dec 31, 2022$79.87M—RevenueFromContractWithCustomerExcludingAssessedTax10-K filed Feb 14, 2025

Quarterly revenue

Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.

QuarterRevenue (USD)vs same quarter a year earlierSource
3 months ended Jun 30, 2026$392.40M+104.5%10-Q filed Aug 5, 2026
3 months ended Mar 31, 2026$308.36M+93.4%10-Q filed May 6, 2026
3 months ended Sep 30, 2025$230.57M+103.9%10-Q filed Nov 5, 2025
3 months ended Jun 30, 2025$191.93M+149.7%10-Q filed Aug 5, 2026
3 months ended Mar 31, 2025$159.44M+144.3%10-Q filed May 6, 2026
3 months ended Sep 30, 2024$113.09M+206.2%10-Q filed Nov 5, 2025
3 months ended Jun 30, 2024$76.85M+619.0%10-Q filed Aug 6, 2025
3 months ended Mar 31, 2024$65.26M+269.4%10-Q filed May 7, 2025

Source: SEC EDGAR XBRL company facts for CIK 1736297 (raw data). Most recent filing in this dataset: 10-Q filed Aug 5, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.